These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15930002)

  • 1. Polyarginine as a multifunctional fusion tag.
    Fuchs SM; Raines RT
    Protein Sci; 2005 Jun; 14(6):1538-44. PubMed ID: 15930002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric ribonuclease as a source of human adapter protein for targeted drug delivery.
    Gaynutdinov TI; Myshkin E; Backer JM; Backer MV
    Protein Eng; 2003 Oct; 16(10):771-5. PubMed ID: 14600207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational stability is a determinant of ribonuclease A cytotoxicity.
    Klink TA; Raines RT
    J Biol Chem; 2000 Jun; 275(23):17463-7. PubMed ID: 10747991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthesis of ribonuclease A using intein-mediated protein ligation.
    Arnold U; Hinderaker MP; Raines RT
    ScientificWorldJournal; 2002 Jun; 2():1823-7. PubMed ID: 12806173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensating effects on the cytotoxicity of ribonuclease A variants.
    Dickson KA; Dahlberg CL; Raines RT
    Arch Biochem Biophys; 2003 Jul; 415(2):172-7. PubMed ID: 12831839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oxidative folding rate of bovine pancreatic ribonuclease is enhanced by a covalently attached oligosaccharide.
    Xu G; Narayan M; Scheraga HA
    Biochemistry; 2005 Jul; 44(28):9817-23. PubMed ID: 16008366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KFERQ sequence in ribonuclease A-mediated cytotoxicity.
    Haigis MC; Kurten EL; Abel RL; Raines RT
    J Biol Chem; 2002 Mar; 277(13):11576-81. PubMed ID: 11801605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of shape-complementarity markers to create cytotoxic variants of ribonuclease A.
    Rutkoski TJ; Kurten EL; Mitchell JC; Raines RT
    J Mol Biol; 2005 Nov; 354(1):41-54. PubMed ID: 16188273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of a hybrid between ribonuclease A and bovine seminal ribonuclease--the basic surface, at 2.0 A resolution.
    Vatzaki EH; Allen SC; Leonidas DD; Trautwein-Fritz K; Stackhouse J; Benner SA; Acharya KR
    Eur J Biochem; 1999 Feb; 260(1):176-82. PubMed ID: 10091597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The S.Tag fusion system for protein purification.
    Raines RT; McCormick M; Van Oosbree TR; Mierendorf RC
    Methods Enzymol; 2000; 326():362-76. PubMed ID: 11036653
    [No Abstract]   [Full Text] [Related]  

  • 11. A ribonuclease A variant with low catalytic activity but high cytotoxicity.
    Bretscher LE; Abel RL; Raines RT
    J Biol Chem; 2000 Apr; 275(14):9893-6. PubMed ID: 10744660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of soluble bovine pancreatic ribonuclease A in Pichia pastoris and its purification and characterization.
    Chatani E; Tanimizu N; Ueno H; Hayashi R
    Biosci Biotechnol Biochem; 2000 Nov; 64(11):2437-44. PubMed ID: 11193413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonuclease A variants with potent cytotoxic activity.
    Leland PA; Schultz LW; Kim BM; Raines RT
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10407-12. PubMed ID: 9724716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the potency of a cytotoxin with an arginine graft.
    Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
    Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
    Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
    J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthesis of cytotoxic proteins using a modified protein splicing element.
    Evans TC; Benner J; Xu MQ
    Protein Sci; 1998 Nov; 7(11):2256-64. PubMed ID: 9827992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of RNase A tandem enzymes and their interaction with the cytosolic ribonuclease inhibitor.
    Arnold U; Leich F; Neumann P; Lilie H; Ulbrich-Hofmann R
    FEBS J; 2011 Jan; 278(2):331-40. PubMed ID: 21134128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flexibility of a distant loop modulates active site motion and product release in ribonuclease A.
    Doucet N; Watt ED; Loria JP
    Biochemistry; 2009 Aug; 48(30):7160-8. PubMed ID: 19588901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.